Description
FSS
Base award description: 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Modification chain · 13 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-08-10+$0= $0
- Mod P000012023-08-23+$0= $0
- Mod P000022023-10-17+$0= $0
- Mod P000032023-10-18+$0= $0
- Mod P000042023-10-25+$0= $0
- Mod P000052024-01-04+$0= $0
- Mod P000062024-06-04+$0= $0
- Mod P000072024-10-31+$0= $0
- Mod P000082025-04-08+$0= $0
- Mod P000092025-08-04+$0= $0
- Mod P000102025-09-16+$0= $0
- Mod P000112025-12-03+$0= $0
- Mod P000122026-05-06+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-08-10 | +$0 | $0 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-08-23 | +$0 | $0 | FSS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-17 | +$0 | $0 | PRODUCT ADDITION MODIFICATION. |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-18 | +$0 | $0 | FSS |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-25 | +$0 | $0 | DELETION |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-04 | +$0 | $0 | FSS |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-04 | +$0 | $0 | PPR |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-10-31 | +$0 | $0 | FSS |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-08 | +$0 | $0 | FSS |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-08-04 | +$0 | $0 | FSS |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-09-16 | +$0 | $0 | 65IB: SIN 42-2A - PRODUCT ADDITION TRANSFER FROM HIKMA SPECIALTY USA INC. 36F79722D0116 |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-03 | +$0 | $0 | PL 2026 PRICE UPDATES |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-05-06 | +$0 | $0 | FSS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Q1MZNNSQUJ53)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77023N0087 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C77023N0062 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $542,736 | FY2023 |
| 36C77022P0206 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $665,184 | FY2022 |
| 36C77022N0074 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $665,184 | FY2022 |
| 36C77022N0065 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $665,184 | FY2022 |
| 36C77022N0060 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $665,184 | FY2022 |
Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D058E | REVOLUTION MEDICINES, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0172 | LUNDBECK LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0165 | RECKITT BENCKISER LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0195 | MILESTONE PHARMACEUTICALS USA, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0118 | OMEROS CORPORATION | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79723D0188_3600 · retrieved 2026-09-26.